Skip to content

Speaker Interview – Dean Falb

Exclusive Interview with Dean Falb, CSO of LogicBio

Dean Falb

Dean is speaking at Hemophilia Drug Development 2019 on Conference Day Two: Thursday 22nd August 2019

 

What would you say are sort of the biggest challenges in advancing gene therapy at the moment?

I think definitely manufacturing is challenging. There are questions about the durability of gene therapy when you treat patients. How long is it going to be lasting in that patient? I think the good news is that you know gene therapies are efficacious which really is a huge win for everybody. So that’s great.

"I think manufacturing and therapeutic durability are the central challenges for gene therapy today."